Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Barber

Showing results (531-540 of 547) with videos related to

Pageof 55
Sort By:
BMC Medicine|November 22, 2021
Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccineRebecca Webster, Silvana Sekuloski, Anand Odedra, et al.
Science Advances|October 4, 2019
IgM in human immunity to <i>Plasmodium falciparum</i> malariaM J Boyle, J A Chan, I Handayuni, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Plos Neglected Tropical Diseases|June 23, 2022
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicityJi-Hoon Park, Min-Hee Kim, Edwin Sutanto, et al.
Open Forum Infectious Diseases|April 11, 2025
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort StudyKaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, et al.
Plos Medicine|October 19, 2020
The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysisAndria Mousa, Abdullah Al-Taiar, Nicholas M Anstey, et al.
Open Forum Infectious Diseases|March 4, 2024
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022Reagan K Barfield, Matthew L Brown, Benjamin Albrecht, et al.
The Lancet. Infectious Diseases|September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Peta Edler, et al.
Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Science Translational Medicine|November 26, 2025
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with <i>Plasmodium falciparum</i>Rebecca Webster, Damian A Oyong, Stacey Llewellyn, et al.
Pageof 55

Showing results (531-540 of 547) with videos related to

Sort By:
Pageof 55
BMC Medicine|November 22, 2021
Safety, infectivity and immunogenicity of a genetically attenuated blood-stage malaria vaccineRebecca Webster, Silvana Sekuloski, Anand Odedra, et al.
Science Advances|October 4, 2019
IgM in human immunity to <i>Plasmodium falciparum</i> malariaM J Boyle, J A Chan, I Handayuni, et al.
The Lancet. Infectious Diseases|September 25, 2023
Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysisMegha Rajasekhar, Julie A Simpson, Benedikt Ley, et al.
Plos Neglected Tropical Diseases|June 23, 2022
Geographical distribution and genetic diversity of Plasmodium vivax reticulocyte binding protein 1a correlates with patient antigenicityJi-Hoon Park, Min-Hee Kim, Edwin Sutanto, et al.
Open Forum Infectious Diseases|April 11, 2025
Real-World Applications of Imipenem-Cilastatin-Relebactam: Insights From a Multicenter Observational Cohort StudyKaylee E Caniff, Nicholas Rebold, Xhilda Xhemali, et al.
Plos Medicine|October 19, 2020
The impact of delayed treatment of uncomplicated P. falciparum malaria on progression to severe malaria: A systematic review and a pooled multicentre individual-patient meta-analysisAndria Mousa, Abdullah Al-Taiar, Nicholas M Anstey, et al.
Open Forum Infectious Diseases|March 4, 2024
A Baker's Dozen of Top Antimicrobial Stewardship Intervention Publications in 2022Reagan K Barfield, Matthew L Brown, Benjamin Albrecht, et al.
The Lancet. Infectious Diseases|September 25, 2023
Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysisRobert J Commons, Megha Rajasekhar, Peta Edler, et al.
Plos Medicine|October 5, 2019
The efficacy of dihydroartemisinin-piperaquine and artemether-lumefantrine with and without primaquine on Plasmodium vivax recurrence: A systematic review and individual patient data meta-analysisRobert J Commons, Julie A Simpson, Kamala Thriemer, et al.
Science Translational Medicine|November 26, 2025
Adjunctive ruxolitinib attenuates inflammation and enhances immunity in volunteers experimentally infected with <i>Plasmodium falciparum</i>Rebecca Webster, Damian A Oyong, Stacey Llewellyn, et al.
Pageof 55